期刊
CLEVELAND CLINIC JOURNAL OF MEDICINE
卷 84, 期 -, 页码 E20-E24出版社
CLEVELAND CLINIC
DOI: 10.3949/ccjm.84.s4.05
关键词
-
资金
- Abbott Vascular
- Biosensors International
- Biotronik
- Boston Scientific
- Edwards Lifesciences
Drug-eluting stents (DES) are increasingly being used as a less invasive alternative to coronary artery bypass grafting. Early generation DES had durable polymers that provided acceptable efficacy outcomes but had high rates of stent thrombosis leading to myocardial infarction and death. Second-generation DES have improved outcomes by reducing stent thrombosis and recurrent stenosis. Newer DES with biodegradable polymers have similar efficacy as second-generation DES, but have higher rates of stent thrombosis. This review compares outcomes of bioresorbable scaffolds and looks at stent technology developments that may improve outcomes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据